Contribution: Regional Economic Growth through Innovation
Augurex Life Sciences Corp.
$473,500.00
000020377
EF 2021-22 · 2022-01-27
Résumé
Support sales and marketing of autoimmune disease test for the point-of-care market
Ministère
Programme
Regional Economic Growth through Innovation
Bénéficiaire
Emplacement
Vancouver, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
829919521
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2025-03-31
Agreement Number
000020377
Agreement Start Date
2022-01-27
Agreement Title
000020377
Agreement Title (French)
000020377
Agreement Type
Contribution
Agreement Value
$473,500.00
Amendment Number
0
Description
Support sales and marketing of autoimmune disease test for the point-of-care market
Description (French)
Soutenir les ventes et la commercialisation d'un test de dépistage des maladies auto-immunes sur le marché des analyses hors laboratoire
Expected Results
Western Canadian businesses are competitive and export their products/services.
Expected Results (French)
Les entreprises de l'Ouest canadien sont concurrentielles et exportent leurs produits et services.
Federal Riding
Vancouver East
Federal Riding (French)
Vancouver-Est
Federal Riding Number
35
NAICS Code
541710
Organization Code
pacifican
Organization
Pacific Economic Development Canada | Développement économique Canada pour le Pacifique
Program Name
Regional Economic Growth through Innovation
Program Name (French)
Croissance économique régionale par l'innovation
Program Purpose
Provide streamlined, nationally consistent and yet regionally tailored support for business productivity and scale-up, particularly for small and medium-sized enterprises (SMEs) and women entrepreneurs and other underrepresented groups, and assist the enhancement of regional industrial and technology clusters and regional innovation ecosystems.
Program Purpose (French)
Fournir un soutien simplifié uniforme à l'échelle nationale mais adapté à l'échelle régionale pour la productivité et la croissance des entreprises, particulièrement au profit des petites et moyennes entreprises (PME) et des femmes entrepreneurs et autres groupes sous-représentés, et contribuer à l'amélioration des grappes industrielles et technologiques régionales et des écosystèmes d'innovation régionaux.
Recipient Business Number
829919521
Recipient City
Vancouver
Recipient Country
CA
Recipient Legal Name
Augurex Life Sciences Corp.
Recipient Operating Name
Augurex Life Sciences Corp
Recipient Postal Code
V5T 4T5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
GC-WD-DEO-2021-2022-Q4-241
